Second Century Ventures Joins the Oxford Future of Real Estate Initiative
News provided by
Share this article
Share this article
CHICAGO, Jan. 12, 2021 /PRNewswire/ Second Century Ventures, the strategic investment arm of the National Association of Realtors
®, has joined the Oxford Saïd Business School s Future of Real Estate Initiative. Second Century Ventures is the most active global fund in real estate and operates the award-winning REACH technology growth program. Through this initiative, SCV will collaborate with FORE s industry partners and academics to address key questions around the future of global real estate.
Through partnerships with several industry leaders, including Arcadis UK, CBRE, EY, and Redevco, the FORE Initiative aims to predict many of the changes and challenges real estate can expect to face over the next decade. In joining the program, SCV looks to provide resources and support to the University of Oxford s Research team s efforts akin to that o
Second Century Ventures Joins the Oxford Future of Real Estate Initiative — RISMedia rismedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rismedia.com Daily Mail and Mail on Sunday newspapers.
With her family set to go, Emily’s kids are especially excited to go away. The kids have had a really hard year, so we just want to get away and forget about things for a while, she said.
For accommodation providers, Sydney s COVID-19 outbreak has disrupted bookings. Blue Mountains AirBnB host Julie Parker has had multiple guests cancel their trips and is now seeing a new wave of cancellations on the horizon. I would have mid-week bookings and every weekend booked out normally during this time of year. I’ve had not one week-long booking, she said. All of a sudden, once the COVID news came out, we got a cancellation for this weekend…People aren’t keen to travel.
As a group, health-care stocks trade at discounted valuations and make up less than 14% of the S&P 500’s market weighting. That seems unlikely to last, says Citi, given that health-care spending is 18% of the economy and growing. “[W]e expect the sector to at least come up to averages,” say the Citi analysts, “implying upside/outperformance for 2021.”
AstraZeneca (ticker: AZN) is the top pharma pick of Citi analyst Andrew Baum. Complementing the strong sales of Astra’s cancer drug Tagrisso are the rising sales of its cancer treatments Imfinzi and Calquence. Other building blockbusters include the diabetes treatment Farxiga. Baum thinks the stock could rise by one-third from its recent price of $49.
The Washington Post, citing a Centers for Disease Control and Prevention study, reported the number of annual HIV diagnoses has dropped by 19 percent between 2005 and 2014.
Men who have sex with other men accounted for around 67 percent of all HIV diagnoses in 2014.
HIV cases among women fell by. Read More.